Instalab

Cashew (Ana o 2) IgE Test Blood

A more precise read on true cashew allergy, beyond what standard cashew testing can show.

Should you take a Cashew (Ana o 2) IgE test?

This test is most useful if any of these apply to you.

Reacted After Eating Cashew
If you've had hives, swelling, or worse after cashew, this test helps confirm whether it was a true allergy and what to avoid.
Positive on a Standard Cashew Test
If your basic cashew IgE was positive but you've never reacted, this test helps separate harmless sensitization from real clinical allergy.
Parent of a Child With Tree Nut Allergy
If your child has any tree nut allergy, component testing refines which nuts truly pose risk and may help avoid unnecessary restrictions.
Considering an Oral Food Challenge
If your allergist is weighing a supervised food challenge, this test can shift the decision and sometimes avoid the challenge entirely.

About Cashew (Ana o 2) IgE

If you or your child has ever had an unexplained reaction after eating cashew, or a standard cashew test came back positive without a clear story behind it, this test can help separate real allergy from harmless sensitization. Cashew reactions tend to be severe when they happen, so getting the diagnosis right matters.

This test measures Ana o 2 (a specific cashew storage protein) IgE in your blood, one of three component-resolved markers used to refine cashew allergy diagnosis. It is part of a newer generation of allergy testing that looks at individual proteins inside the nut rather than the whole extract.

What This Test Actually Measures

Cashew nuts contain three main allergenic proteins: Ana o 1, Ana o 2, and Ana o 3. A standard cashew IgE test mixes all of these proteins together and measures your antibody response to the whole extract. The problem is that a positive result on the extract test does not reliably tell you whether you will actually react to eating cashew. Many people show sensitization without true clinical allergy.

Ana o 2-specific IgE measures your antibodies to just one protein inside cashew. Your immune system makes IgE antibodies when it has been primed to recognize a specific allergen. When those antibodies later encounter the protein again, they can trigger immune cells to release histamine and other inflammatory chemicals, producing symptoms that range from mild itching to anaphylaxis (a severe, whole-body allergic reaction).

Why Component Testing Beats Whole Cashew IgE

In a prospective study of 173 children who underwent supervised food challenges, IgE to Ana o 1, Ana o 2, and Ana o 3 each individually predicted whether a child would actually react to cashew. The discriminative ability for Ana o 2 (c-index 0.85, a statistical measure of how well a test separates two groups, where 1.0 is perfect) clearly beat whole cashew IgE (0.76) and matched skin prick testing (0.83). At the highest component IgE levels, the risk of a true allergic reaction approached 100%.

Because the three cashew components are biologically related and your antibody response to them tends to track together, measuring one component is usually enough to refine the picture. Ana o 3 is the most studied of the three, with cohorts showing strong sensitivity and specificity for true cashew allergy in children. Ana o 2 has similar diagnostic value, though its individual cutoffs are less precisely defined.

Cashew Allergy and the Risk of Severe Reactions

Cashew has become one of the most common triggers of food-induced anaphylaxis in children. Anaphylaxis registry data covering 1,389 nut-allergic patients identified cashew as the most frequent cause of anaphylaxis in pediatric cases. Sensitization to the cashew storage proteins, especially the 2S albumin family that includes Ana o 3, is associated with higher risk of severe reactions rather than mild oral symptoms.

There is an important caveat here: no IgE test, including component testing, reliably predicts how severe your next reaction will be. A high Ana o 2 IgE points to a real allergy that warrants strict avoidance and an epinephrine auto-injector, but the actual severity of any given exposure depends on dose, cofactors, and individual variability that no blood test can capture.

Cross-Reactivity With Pistachio

Cashew and pistachio belong to the same botanical family, and their storage proteins share enough structure that IgE antibodies often recognize both. Studies show that Ana o 3-based testing predicts pistachio allergy with strong accuracy. If you have a positive cashew component test, you are at meaningfully elevated risk for reacting to pistachio as well, even if you have never knowingly eaten it.

Reducing the Need for Oral Food Challenges

The gold-standard test for food allergy is an oral food challenge, where you eat increasing amounts of the food under medical supervision. These challenges are time-consuming, expensive, and carry real risk of triggering a reaction. A cost analysis comparing diagnostic strategies found that using Ana o 3 IgE alone or in a two-step model (whole cashew IgE first, then component testing) reduced the number of oral food challenges needed and cut diagnostic costs substantially compared with skin prick testing alone.

Tracking Your Trend

A single component IgE result is more informative than a single extract IgE, but tracking over time tells you more than any one number. Cashew allergy can resolve spontaneously in some children, and falling component IgE levels are one of the signals clinicians use to consider a supervised re-challenge. If you are diagnosed with cashew allergy, retesting every 12 to 24 months can show whether your antibody response is stable, climbing, or trending downward.

If you are testing for the first time because of a suspected reaction, the typical pattern is to get a baseline now, repeat in 6 to 12 months if levels are borderline or if symptoms have not recurred, and then annually thereafter. Children whose Ana o IgE values drift down over time may eventually be candidates for an oral food challenge to assess whether tolerance has developed.

What to Do With an Unexpected Result

A clearly elevated Ana o 2 IgE in someone with a history of reacting to cashew confirms the diagnosis and supports strict avoidance plus an epinephrine prescription. A clearly negative result in someone with no symptoms makes clinical cashew allergy unlikely. The gray zone is where decisions get harder.

If your result is borderline, or if it does not match your history, the right next step is a referral to an allergist rather than acting on the number alone. Companion tests that complement Ana o 2 include whole cashew IgE, Ana o 3, skin prick testing, and component testing for related nuts (pistachio, walnut, hazelnut, peanut). An allergist can also decide whether a supervised oral food challenge is warranted. Do not start or stop avoidance based on a single component IgE without clinical context.

Where This Test Sits in the Evidence Spectrum

Cashew component IgE is an emerging marker. Published research shows strong diagnostic accuracy, especially for Ana o 3, but standardized clinical cutoffs vary between labs and populations, and Ana o 2 specifically has been less individually quantified than Ana o 3. The test is best interpreted by a clinician familiar with food allergy diagnostics, alongside your history, other allergy tests, and sometimes a food challenge.

What Moves This Biomarker

Evidence-backed interventions that affect your Cashew (Ana o 2) IgE level

↓ Decrease
Cashew oral immunotherapy
Gradually exposing you to small, increasing doses of cashew protein under medical supervision can desensitize your immune system over months and is associated with changes in allergen-reactive immune cells. In the NUT CRACKER study of 50 cashew-allergic patients, most achieved desensitization, with cross-desensitization to pistachio. Safety profile is similar to other food immunotherapies, meaning allergic reactions during the buildup phase are common. This is a specialist-supervised treatment, not something to attempt on your own.
MedicationModerate Evidence
↓ Decrease
Omalizumab (anti-IgE monoclonal antibody)
Omalizumab is an injectable medication that binds free IgE antibodies in your blood, reducing their ability to trigger allergic reactions. In a randomized trial of 180 patients with multiple food allergies, 16 to 20 weeks of omalizumab raised the reaction threshold for peanut and other food allergens compared with placebo. The effect on cashew-specific component IgE was not directly measured, but the drug lowers IgE-driven reactivity across food allergens generally.
MedicationModerate Evidence
↓ Decrease
Natural resolution over time in children
Some children with cashew allergy outgrow it spontaneously without any intervention, and falling component IgE levels reflect this. A natural history study of children with pediatric cashew allergy documented clinical resolution in a subset, with declining IgE among the predictors. If your child has cashew allergy, periodic retesting can show whether levels are trending downward toward potential tolerance.
LifestyleModest Evidence

Frequently Asked Questions

References

15 studies
  1. Valk J, Van Wijk R, Vergouwe Y, Steyerberg E, Reitsma M, Wichers H, Savelkoul H, Vlieg-boerstra B, De Groot H, Dubois AE, De Jong NWClinical & Experimental Allergy2017
  2. Lange L, Lasota L, Finger a, Vlajnic D, Busing S, Meister J, Broekaert I, Pfannenstiel C, Friedrichs F, Price M, Trendelenburg V, Niggemann B, Beyer KAllergy2017
  3. Dang T, Peters R, Neeland M, Brettig T, Green HM, Mcwilliam V, Tang M, Dharmage S, Ponsonby a, Koplin J, Perrett KPediatric Allergy and Immunology2021
  4. Savvatianos S, Konstantinopoulos a, Borga a, Stavroulakis G, Lidholm J, Borres M, Manousakis E, Papadopoulos NThe Journal of Allergy and Clinical Immunology2015
  5. Rontynen P, Kukkonen K, Savinko T, Makela MAnnals of Allergy, Asthma & Immunology2021